Entrada Therapeutics Inc — Quarterly Cash Flow (NASDAQ:TRDA) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Total assets 554.59 M526.32 M486.48 M448.78 M412.9 M377.38 M Total liabilities 132.14 M97.64 M69.22 M69.28 M72.18 M71.25 M Total equity 422.45 M428.68 M417.26 M379.5 M340.72 M306.13 M Total liabilities & shareholders' equities 554.59 M526.32 M486.48 M448.78 M412.9 M377.38 M Total debt —————— Net debt ——————

뉴스

Lucro da Entrada Therapeutics superou projeções por $0,04; receita menor do que estimativas

Entrada Therapeutics earnings beat by $0.04, revenue fell short of estimates

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Repligen (RGEN) Tops Q4 Earnings and Revenue Estimates

Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline

EyePoint (EYPT) Surges 15.2%: Is This an Indication of Further Gains?

Illumina (ILMN) Tops Q4 Earnings and Revenue Estimates

Techne (TECH) Beats Q2 Earnings and Revenue Estimates

Entrada Therapeutics, Inc. (TRDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Capricor Therapeutics Stock: A High Risk/High Reward Name (NASDAQ:CAPR)

Entrada reports progress on DMD treatments, shares clinical timeline

Analista do TD Cowen destaca mais de 10 potenciais catalisadores em biotecnologia para 2026